Marc de Rooij

Nordian Capital BV(Nordian Capital), formerly known as Rabo Capital an independent Netherlands based private equity firm which was founded in September 2014 as a spinoff from Rabobank.

Anterra Capital BV (Anterra Capital) is an independent private equity firm founded in 2013. The firm is headquartered in Amsterdam, Netherlands.

NBI Investors is an independent fund manager that is responsible for the day to day management, which was founded in 2014 . The firm headquartered in Netherlands.

Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden.

Part of Akzo Nobel NV, Akzo Nobel Paints LLC is a company that has been pioneering the world of possibilities in coatings for over 200 years. Based in Strongsville, OH, the most sustainable paints company has been inventing the future for more than two centuries. The company's world-class portfolio of brands, including Dulux, International, Sikkens, and Interpon, is trusted by customers worldwide. With a presence in over 150 countries, the company aims to become the industry leader.

NPM Capital NV is a Private Equity firm, a subsidiary of SHV Holdings NV founded in 1948. NPM Capital NV is headquartered in Amsterdam with additional office in Brussels.

Arlon Capital Partners Management Co. LLC (Arlon Capital Partners) is a private equity firm subsidiary of Arlon Group LLC founded in 2007. The firm is is headquartered in New York.

De Gentse Kluis SA engages in the supply of frozen ready to eat meals. The company was founded on July 5, 2006 and is headquartered in Veurne, Belgium.

Victus Participations BV is an Independent Private Equity firm founded in 2017. Victus Participations BV is headquartered in Amsterdam.

KplusV Startgreen Investment Services BV is an independent private equity firm with its headquarters in Amsterdam, the Netherlands. It was founded in 2013.

IBS Capital Management BV is an alternative investment manager based in the Netherlands. The Dutch company acts as an investment manager for alternative investments. Harold Knebel has been the CEO of the private company since 2016.

Robin Radar Systems BV develops and manufactures avian radars. It offers products that include 2D Mobile, 3D Fixed, 3D Flex and Military XL. The firm's bird detection systems are purpose-built to give an accurate, continuous, real-time view of bird movements. The company was founded by Jeroen Wortelboer, Addy Borst, Wouter Keijer and Siete Hamminga in 2010 and is headquartered in The Hague, the Netherlands.

Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA.

Enko Chem, Inc. operates as a biotechnology company. The company was founded by Jacqueline Heard and is headquartered in Boston, MA.

Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.

AgriMetis LLC operates a biotech company, which engages in the development of crop protection agents. It also offers natural products derived compounds to protect crops from weeds, fungal diseases, and insect pests. Its AgriMetis technology platform employs multidisciplinary and integrated scientific approach that allows access to areas of chemical space and production routes that are inaccessible to others. The company was founded by Philip Goelet, Simon Aspland and Brian Green in March 2014 and is headquartered in Lutherville, MD.

Ceradis BV develops and markets environmental solutions for plant nutrition, crop protection, and formulation services. It focuses on the use of biological formulation additives and the development of biofungicides based on macro-organisms or natural products. The company was founded by Wim M. van der Krieken in 2005 and is headquartered in Wageningen, the Netherlands.

Schoenendoos Rotterdam BV is a private equity firm with headquarters in Rotterdam, The Netherlands. It was founded in 2017.

Gilde Equity Management is a Private Equity firm founded in 1996. The firm is headquartered in Heemstede Estate, Netherlands.

FB Oranjewoud Participaties BV is a private equity firm, a subsidiary of Stichting FB Oranjewoud founded in 2012. The firm is headquartered in Oranjewoud, the Netherlands.

D.M. Equity General Partners BV is an independent private equity firm with its headquarters in Schiphol, the Netherlands. It was founded in 2016.

OOK Capital Partners BV is an independent private equity firm with its headquarters in Naarden, the Netherlands. It was founded in 2013.

Selo Holding BV offers packaging solutions and complete production lines. It designs and implements processing and packaging systems for customers in the food manufacturing, animal feed, pharmaceutical and non-food industries. The company offers food processing, meat machinery, packaging machines, artificial casings, and pet food equipment. It has offices in Aarhus, Antwerp, Argenbühl, Brie-Comte-Robert, Merseyside and Oldenzaal. Selo Holding was founded in 1989 and is headquartered in Oldenzaal, the Netherlands.

Van Wijnen Holding NV operates as a financial holding company with activities in the construction and property development industry. The company is headquartered in Baarn, the Netherlands.

Dualyx NV is a biotech company based in Ghent, Belgium that focuses on developing novel Treg-based therapies for patients with difficult-to-treat autoimmune diseases. The CEO of the company is Wouter Verhoeven, and it is located in Zwijnaarde, Belgium. Dualyx has developed a pipeline of highly promising immune modulating programs, including DT-001, an antibody agonist program targeting the TNF receptor 2 (TNFR2), which is currently in IND-enabling studies. The Belgian company aims to create next-generation biologic drugs for autoimmunity therapies with novel mechanisms of action, lower toxicity, and improved patient outcomes than traditional therapeutics. The company was founded in 2020 by Luc van Rompaey in collaboration with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven.